Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy

Schnepel J, Unger J, Tschesche H (2001)
BIOLOGICAL CHEMISTRY 382(12): 1707-1714.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ;
Abstract
The N-terminal heparin/fibrin binding domain of human plasma fibronectin (pFN) contains a cryptic proteinase. The enzyme could be generated and activated in the presence of Ca2+ from the purified 70 kDa pFN fragment produced by cathepsin D digestion of pFN. In this work we cloned and expressed the serine proteinase, designated fibronectinase (Fnase), in E. coli. The recombinant pFN protein fragment was isolated from inclusion bodies, subjected to folding and autocatalytic degradation in the presence of Ca2+, and yielded an active enzyme capable of digesting fibronectin. Cleavage of pFN and the synthetic peptides Ac-I-E-G-K-pNA and Bz-I-E-G-R-pNA demonstrated identical specificity of the recombinant and the isolated fibronectinase. Further investigations of the substrate specificity revealed for the first time the muscle proteins actin and myosin as being substrates of fibronectinase. The enzyme can be inhibited by alpha(1)-proteinase inhibitor. In the context of induced cathepsin D release, e. g. from granulocytes under inflammatory conditions, these results indicate an increase in specific proteolytic potential against muscular proteins in dystrophic diseases by the release of cryptic fibronectinase.
Publishing Year
ISSN
PUB-ID

Cite this

Schnepel J, Unger J, Tschesche H. Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy. BIOLOGICAL CHEMISTRY. 2001;382(12):1707-1714.
Schnepel, J., Unger, J., & Tschesche, H. (2001). Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy. BIOLOGICAL CHEMISTRY, 382(12), 1707-1714.
Schnepel, J., Unger, J., and Tschesche, H. (2001). Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy. BIOLOGICAL CHEMISTRY 382, 1707-1714.
Schnepel, J., Unger, J., & Tschesche, H., 2001. Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy. BIOLOGICAL CHEMISTRY, 382(12), p 1707-1714.
J. Schnepel, J. Unger, and H. Tschesche, “Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy”, BIOLOGICAL CHEMISTRY, vol. 382, 2001, pp. 1707-1714.
Schnepel, J., Unger, J., Tschesche, H.: Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy. BIOLOGICAL CHEMISTRY. 382, 1707-1714 (2001).
Schnepel, J, Unger, J, and Tschesche, Harald. “Recombinant cryptic human fibronectinase cleaves actin and myosin: Substrate specificity and possible role in muscular dystrophy”. BIOLOGICAL CHEMISTRY 382.12 (2001): 1707-1714.
This data publication is cited in the following publications:
This publication cites the following data publications:

3 Citations in Europe PMC

Data provided by Europe PubMed Central.

Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration.
Houard X, Germain S, Gervais M, Michaud A, van den Brule F, Foidart JM, Noel A, Monnot C, Corvol P., Int. J. Cancer 116(3), 2005
PMID: 15800942

28 References

Data provided by Europe PubMed Central.


Vuento, Biochem. J. 183(), 1979
Immunocytochemical studies of cathepsin D in human skeletal muscle.
Whitaker JN, Bertorini TE, Mendell JR., Ann. Neurol. 13(2), 1983
PMID: 6338808

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 11843184
PubMed | Europe PMC

Search this title in

Google Scholar